J.P. Bahary

520 total citations
21 papers, 388 citations indexed

About

J.P. Bahary is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Genetics. According to data from OpenAlex, J.P. Bahary has authored 21 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiation and 8 papers in Genetics. Recurrent topics in J.P. Bahary's work include Advanced Radiotherapy Techniques (10 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Glioma Diagnosis and Treatment (8 papers). J.P. Bahary is often cited by papers focused on Advanced Radiotherapy Techniques (10 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Glioma Diagnosis and Treatment (8 papers). J.P. Bahary collaborates with scholars based in Canada, United States and Japan. J.P. Bahary's co-authors include Walter J. Curran, Maria Werner‐Wasik, Charles Scott, Luís Souhami, Raul C. Urtasun, John Del Rowe, B. Fisher, Jean‐Guy Villemure, Jean Raymond and F Guilbert and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and International Journal of Obesity.

In The Last Decade

J.P. Bahary

20 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Bahary Canada 11 202 184 100 82 64 21 388
J. Curschmann Switzerland 4 172 0.9× 331 1.8× 57 0.6× 115 1.4× 98 1.5× 6 431
Denise Damek United States 9 143 0.7× 328 1.8× 176 1.8× 67 0.8× 40 0.6× 19 411
Jean-Yves Delattre France 10 177 0.9× 240 1.3× 34 0.3× 81 1.0× 52 0.8× 11 306
Fred Hsu Canada 11 300 1.5× 150 0.8× 44 0.4× 75 0.9× 59 0.9× 22 433
Alessandra Mirri Italy 9 159 0.8× 111 0.6× 36 0.4× 40 0.5× 45 0.7× 15 307
Ho Shin Gwak South Korea 8 227 1.1× 150 0.8× 53 0.5× 89 1.1× 27 0.4× 16 312
Renate Haselmann Germany 7 212 1.0× 148 0.8× 31 0.3× 40 0.5× 86 1.3× 9 352
John H. Suh United States 7 235 1.2× 101 0.5× 43 0.4× 56 0.7× 34 0.5× 9 326
Vimoj Nair Canada 11 145 0.7× 114 0.6× 25 0.3× 52 0.6× 76 1.2× 32 308
X. Murraciole France 5 152 0.8× 225 1.2× 57 0.6× 57 0.7× 29 0.5× 13 323

Countries citing papers authored by J.P. Bahary

Since Specialization
Citations

This map shows the geographic impact of J.P. Bahary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Bahary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Bahary more than expected).

Fields of papers citing papers by J.P. Bahary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Bahary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Bahary. The network helps show where J.P. Bahary may publish in the future.

Co-authorship network of co-authors of J.P. Bahary

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Bahary. A scholar is included among the top collaborators of J.P. Bahary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Bahary. J.P. Bahary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gondi, Vinai, S. Pugh, Thomas L. Chenevert, et al.. (2020). Radiotherapy (RT) Dose-intensification (DI) Using Intensity-modulated RT (IMRT) versus Standard-dose (SD) RT with Temozolomide (TMZ) in Newly Diagnosed Glioblastoma (GBM): Preliminary Results of NRG Oncology BN001. International Journal of Radiation Oncology*Biology*Physics. 108(3). S22–S23. 33 indexed citations
2.
Bélanger, K., Nathalie Letarte, Jean‐Philippe Adam, et al.. (2018). Procarbazine, Lomustine and Vincristine Toxicity in Low-Grade Gliomas. Current Oncology. 25(1). 33–39. 16 indexed citations
3.
Jones, Christopher U., S. Pugh, Howard M. Sandler, et al.. (2018). Long-Term Update of NRG Oncology RTOG 94-08. International Journal of Radiation Oncology*Biology*Physics. 102(3). S31–S32. 1 indexed citations
4.
Fleming, Jessica L., Erica H. Bell, Susan M. Chang, et al.. (2018). Elevated MGMT Gene Expression is Independently Associated with Worse Overall Survival in NRG Oncology/RTOG 9813: A Phase III Study of Radiation Therapy (RT) and Temozolomide (TMZ) Versus RT and Nitrosourea (NU) in Anaplastic Grade III Glioma. International Journal of Radiation Oncology*Biology*Physics. 102(3). S46–S47. 1 indexed citations
5.
Bell, Erica H., Minhee Won, Susan M. Chang, et al.. (2017). MGMT Promoter Methylation Status Independently Predicts Overall Survival in Anaplastic Astrocytoma in NRG Oncology/RTOG 9813: A Phase 3 Trial of Radiation Plus Nitrosourea Versus Radiation Plus Temozolomide. International Journal of Radiation Oncology*Biology*Physics. 99(2). S99–S100. 2 indexed citations
6.
Shipley, William U., Wendy Seiferheld, Himu Lukka, et al.. (2015). Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA. International Journal of Radiation Oncology*Biology*Physics. 94(1). 3–3. 14 indexed citations
7.
Krauss, Daniel, Daniel Hunt, J.P. Bahary, et al.. (2013). Inferior Clinical Outcomes for Patients With Positive Post-Radiation Therapy Prostate Biopsy: Results From Prospective Randomized Trial RTOG 94-08. International Journal of Radiation Oncology*Biology*Physics. 87(2). S23–S23. 1 indexed citations
8.
Mak, Raymond H., Daniel Hunt, William U. Shipley, et al.. (2012). Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury. International Journal of Radiation Oncology*Biology*Physics. 84(3). S14–S14. 4 indexed citations
9.
Michalski, Jeff M., Søren M. Bentzen, Kathryn Winter, et al.. (2012). Dose Volume Analysis of Grade 2+ Late GI Toxicity on RTOG 0126 After High-dose 3DCRT or IMRT. International Journal of Radiation Oncology*Biology*Physics. 84(3). S14–S15. 2 indexed citations
10.
Zilli, Thomas, Nguyễn Văn Tiến, J.P. Bahary, et al.. (2011). Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy. International Journal of Obesity. 35(11). 1421–1426. 20 indexed citations
11.
Bing, F., Frédéric Lacroix, J.P. Bahary, et al.. (2011). Liquid Embolization Material Reduces the Delivered Radiation Dose: Clinical Myth or Reality?. American Journal of Neuroradiology. 33(2). 320–322. 30 indexed citations
12.
Igidbashian, Levon, et al.. (2008). Poor Predictive Value of Intraoperative Real-time Dosimetry for Prostate Seed Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 72(1). S567–S567. 2 indexed citations
14.
Raymond, Jean, Daniela Iancu, Alain Weill, et al.. (2005). Embolization as One Modality in a Combined Strategy for the Management of Cerebral Arteriovenous Malformations. Interventional Neuroradiology. 11(1_suppl). 57–62. 21 indexed citations
15.
Sperduto, Paul W., Charles Scott, David W. Andrews, et al.. (2002). Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: report of radiation therapy oncology group phase III study 95–08. International Journal of Radiation Oncology*Biology*Physics. 54(2). 3–3. 54 indexed citations
16.
Rowe, John Del, Charles Scott, Maria Werner‐Wasik, et al.. (2000). Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme. Journal of Clinical Oncology. 18(6). 1254–1259. 76 indexed citations
17.
Hoyt, William F., et al.. (1999). 2092 Improved visual outcome with definitive radiation therapy for optic nerve sheath meningioma. International Journal of Radiation Oncology*Biology*Physics. 45(3). 324–325. 9 indexed citations
18.
Gasecki, Andrew P., Carmelo Graffagnino, Vladimir Hachinski, & J.P. Bahary. (1997). Tissue Plasminogen Activator in a Vertebral Artery Dissection. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 24(2). 151–157. 1 indexed citations
19.
Shenouda, George, Luís Souhami, E. B. Podgoršak, et al.. (1997). Radiosurgery and Accelerated Radiotherapy for Patients with Glioblastoma. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 24(2). 110–115. 29 indexed citations
20.
Bahary, J.P., Jean‐Guy Villemure, Richard Leblanc, et al.. (1996). Low-grade pure and mixed cerebral astrocytomas treated in the CT scan era. Journal of Neuro-Oncology. 27(2). 173–7. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026